Home / Economy / Jean-Elie Malkin: Georgia Should Put Few Regulations on Pharmaceutical Issues
Jean-Elie Malkin: Georgia Should Put Few Regulations on Pharmaceutical Issues

Jean-Elie Malkin: Georgia Should Put Few Regulations on Pharmaceutical Issues

Conference hall of National Center of Disease Control and Public Health of Georgia (NCDC) hosted a conference on The Quality of Medical Products in Georgia.

Minister David Sergeenko, Dr. Jean-Elie Malkin, Dr. Caroline Mascret, Deputy minister Valeri Kvaratskhelia and other members of regulation agency attended the conference.

Georgia has signed The Association Agreement with the European Union in 2014. This agreement foresees adoption of a few new regulations. With regard to medicinal products, Georgia is expected to adopt amendments to its national law on drugs and medicinal products and other regulations in terms of registering and licensing these products.

Taking into account these issues the president of Global Alliance, Jean-Elie Malkin talked with the local media.

The situation of the pharmaceutical  market in Georgia could and should be improved and I know that the authorities, especially Ministry of Health is intensively working for implementing this project properly. Global Alliance supports the Ministry in improving pharmaceutical procedures and regulations.

The main issues that were discussed at the conference were the quality, affordable prices of drugs and the doctors’ responsibility in prescribing the right medicaments.

If you don’t have a good doctor who prescribes right drugs, quality of the drug won’t be efficient. If a medical facility is not good, the result won’t be efficient. The quality of the drug is vital and quality of the health care service delivery is important as well, we have to interconnect all of these elements,” Jean-Elie Malkin noted.

What Georgia could do in order to improve the situation is once again to put a little bit more regulations on the pharmaceutical issues.

The conference and the presentations addressed issues connected to the registration and distribution of medicinal products, adopting the EU and other stringent regulatory countries’ standards in terms of registering, licensing pharmacovigilance, GMP, quality control and other issues that will ensure Georgia’s adherence to the commitments undertaken within the frames of the relevant agreements.

By Nutsa Galumashvili
More by By Nutsa Galumashvili